메뉴 건너뛰기




Volumn 72, Issue 3, 2015, Pages 261-266

Knowledge, use and perceptions of probiotics and prebiotics in hospitalised patients

Author keywords

Clinical nutrition and dietetics, clinical trials; Consumers; Dietary intake; Food preferences; Health beliefs

Indexed keywords


EID: 84943351419     PISSN: 14466368     EISSN: 17470080     Source Type: Journal    
DOI: 10.1111/1747-0080.12177     Document Type: Article
Times cited : (37)

References (28)
  • 1
    • 0034492970 scopus 로고    scopus 로고
    • Perspectives on the role of the human gut microbiota and its modulation by pro- and prebiotics
    • Steer T, Carpenter H, Tuohy K, Glenn GR. Perspectives on the role of the human gut microbiota and its modulation by pro- and prebiotics. Nutr Res Rev 2000; 13: 229-254.
    • (2000) Nutr Res Rev , vol.13 , pp. 229-254
    • Steer, T.1    Carpenter, H.2    Tuohy, K.3    Glenn, G.R.4
  • 2
    • 4444234608 scopus 로고    scopus 로고
    • Joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria
    • accessed 12 October 2011
    • Food and Agriculture Organization/World Health Organization. Joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria, 2001. (Available from: ftp://ftp.fao.org/docrep/fao/009/a0512e/a0512e00.pdf, accessed 12 October 2011).
    • (2001)
  • 3
    • 79953778118 scopus 로고    scopus 로고
    • Probiotic market- advanced Technologies and global market (2009-2014)
    • accessed 1 October 2009
    • Markets and Markets. Probiotic market- advanced Technologies and global market (2009-2014), 2009. (Available from: www.marketsandmarkets.com, accessed 1 October 2009).
    • (2009)
  • 4
    • 12744273405 scopus 로고    scopus 로고
    • Dietary modulation of the human colonic microbiota: updating the concept of prebiotics
    • Gibson GR, Probert HM, Loo JV, Rastall RA, Roberfroid MB. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 2004; 17: 259-275.
    • (2004) Nutr Res Rev , vol.17 , pp. 259-275
    • Gibson, G.R.1    Probert, H.M.2    Loo, J.V.3    Rastall, R.A.4    Roberfroid, M.B.5
  • 5
    • 0005200297 scopus 로고    scopus 로고
    • Effects of consumption of a fermented milk by the probiotic strain Bifidobacterium animalis DN-173 010 on the colonic transit times in healthy humans
    • Bouvier M, Meance S, Bouley C, Berta JL, Grimaud JC. Effects of consumption of a fermented milk by the probiotic strain Bifidobacterium animalis DN-173 010 on the colonic transit times in healthy humans. Biosci Microflora 2001; 20: 43-48.
    • (2001) Biosci Microflora , vol.20 , pp. 43-48
    • Bouvier, M.1    Meance, S.2    Bouley, C.3    Berta, J.L.4    Grimaud, J.C.5
  • 6
    • 0036185671 scopus 로고    scopus 로고
    • Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women: a double-blind, randomised, controlled study
    • Marteau P, Cuillerier E, Meance S etal. Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women: a double-blind, randomised, controlled study. Aliment Pharmacol Ther 2002; 16: 587-593.
    • (2002) Aliment Pharmacol Ther , vol.16 , pp. 587-593
    • Marteau, P.1    Cuillerier, E.2    Meance, S.3
  • 7
    • 0043197149 scopus 로고    scopus 로고
    • Recent advances in the use of functional foods: effects of the commercial fermented milk with Bifidobacterium animalis strain DN-173 010 and yoghurt strains on gut transit time in the elderly
    • Meance S, Cayuela C, Raimondi A, Turchet P, Lucas C, Antoine JM. Recent advances in the use of functional foods: effects of the commercial fermented milk with Bifidobacterium animalis strain DN-173 010 and yoghurt strains on gut transit time in the elderly. Microb Ecol Health Dis 2003; 15: 15-22.
    • (2003) Microb Ecol Health Dis , vol.15 , pp. 15-22
    • Meance, S.1    Cayuela, C.2    Raimondi, A.3    Turchet, P.4    Lucas, C.5    Antoine, J.M.6
  • 8
    • 0030904993 scopus 로고    scopus 로고
    • Effects of inulin and lactose on fecal microflora, microbial activity, and bowel habit in elderly constipated persons
    • Kleessen B, Sykura B, Zunft HJ, Blaut M. Effects of inulin and lactose on fecal microflora, microbial activity, and bowel habit in elderly constipated persons. Am J Clin Nutr 1997; 65: 1397-1402.
    • (1997) Am J Clin Nutr , vol.65 , pp. 1397-1402
    • Kleessen, B.1    Sykura, B.2    Zunft, H.J.3    Blaut, M.4
  • 9
    • 34447298145 scopus 로고    scopus 로고
    • Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomised, double-blind, controlled trial
    • Guyonnet D, Chassany O, Ducrotte P etal. Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomised, double-blind, controlled trial. Aliment Pharmacol Ther 2007; 26: 475-486.
    • (2007) Aliment Pharmacol Ther , vol.26 , pp. 475-486
    • Guyonnet, D.1    Chassany, O.2    Ducrotte, P.3
  • 10
    • 50949100435 scopus 로고    scopus 로고
    • Effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome.
    • Sinn DH, Song JH, Kim HJ etal. Effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome. Dig Dis Sci 2008; 53: 2714-2718.
    • (2008) Dig Dis Sci , vol.53 , pp. 2714-2718
    • Sinn, D.H.1    Song, J.H.2    Kim, H.J.3
  • 11
    • 20844461853 scopus 로고    scopus 로고
    • Treatment effects of partially hydrolyzed guar gum on symptoms and quality of life of patients with irritable bowel syndrome. A multicenter randomised open trial
    • Parisi G, Bottona E, Carrara M etal. Treatment effects of partially hydrolyzed guar gum on symptoms and quality of life of patients with irritable bowel syndrome. A multicenter randomised open trial. Dig Dis Sci 2005; 50: 1107-1112.
    • (2005) Dig Dis Sci , vol.50 , pp. 1107-1112
    • Parisi, G.1    Bottona, E.2    Carrara, M.3
  • 12
    • 0033661618 scopus 로고    scopus 로고
    • Efficacy, safety, and tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome
    • Olesen M, Gudmand-Hoyer E. Efficacy, safety, and tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome. Am J Clin Nutr 2000; 72: 1570-1575.
    • (2000) Am J Clin Nutr , vol.72 , pp. 1570-1575
    • Olesen, M.1    Gudmand-Hoyer, E.2
  • 13
    • 25844477007 scopus 로고    scopus 로고
    • A randomised controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating
    • Kim HJ, Vazquez Roque MI, Camilleri M etal. A randomised controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating. Neurogastroenterol Motil 2005; 17: 687-696.
    • (2005) Neurogastroenterol Motil , vol.17 , pp. 687-696
    • Kim, H.J.1    Vazquez Roque, M.I.2    Camilleri, M.3
  • 14
    • 0037309595 scopus 로고    scopus 로고
    • Randomised controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis
    • Ishikawa H, Akedo I, Umesaki Y, Tanaka R, Imaoka A, Otani T. Randomised controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis. J Am Coll Nutr 2003; 22: 56-63.
    • (2003) J Am Coll Nutr , vol.22 , pp. 56-63
    • Ishikawa, H.1    Akedo, I.2    Umesaki, Y.3    Tanaka, R.4    Imaoka, A.5    Otani, T.6
  • 15
    • 0030611915 scopus 로고    scopus 로고
    • Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis
    • Kruis W, Schutz E, Fric P, Fixa B, Judmaier G, Stolte M. Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 1997; 11: 853-858.
    • (1997) Aliment Pharmacol Ther , vol.11 , pp. 853-858
    • Kruis, W.1    Schutz, E.2    Fric, P.3    Fixa, B.4    Judmaier, G.5    Stolte, M.6
  • 16
    • 0033592203 scopus 로고    scopus 로고
    • Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial
    • Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM, Axon AT. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 1999; 354: 635-639.
    • (1999) Lancet , vol.354 , pp. 635-639
    • Rembacken, B.J.1    Snelling, A.M.2    Hawkey, P.M.3    Chalmers, D.M.4    Axon, A.T.5
  • 17
    • 22744438084 scopus 로고    scopus 로고
    • VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis
    • Bibiloni R, Fedorak RN, Tannock GW etal. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol 2005; 100: 1539-1546.
    • (2005) Am J Gastroenterol , vol.100 , pp. 1539-1546
    • Bibiloni, R.1    Fedorak, R.N.2    Tannock, G.W.3
  • 18
    • 0037783259 scopus 로고    scopus 로고
    • A pilot trial of Saccharomyces boulardii in ulcerative colitis
    • Guslandi M, Giollo P, Testoni PA. A pilot trial of Saccharomyces boulardii in ulcerative colitis. Eur J Gastroenterol Hepatol 2003; 15: 697-698.
    • (2003) Eur J Gastroenterol Hepatol , vol.15 , pp. 697-698
    • Guslandi, M.1    Giollo, P.2    Testoni, P.A.3
  • 19
    • 34848834177 scopus 로고    scopus 로고
    • Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study
    • Hafer A, Kramer S, Duncker S, Kruger M, Manns MP, Bischoff SC. Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study. BMC Gastroenterol 2007; 7: 36.
    • (2007) BMC Gastroenterol , vol.7 , pp. 36
    • Hafer, A.1    Kramer, S.2    Duncker, S.3    Kruger, M.4    Manns, M.P.5    Bischoff, S.C.6
  • 20
    • 29244491643 scopus 로고    scopus 로고
    • Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to helicobacterpylori eradication
    • Duman DG, Bor S, Ozutemiz O etal. Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to helicobacterpylori eradication. Eur J Gastroenterol Hepatol 2005; 17: 1357-1361.
    • (2005) Eur J Gastroenterol Hepatol , vol.17 , pp. 1357-1361
    • Duman, D.G.1    Bor, S.2    Ozutemiz, O.3
  • 21
    • 0036840803 scopus 로고    scopus 로고
    • Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study
    • Cremonini F, Di Caro S, Covino M etal. Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. Am J Gastroenterol 2002; 97: 2744-2749.
    • (2002) Am J Gastroenterol , vol.97 , pp. 2744-2749
    • Cremonini, F.1    Di Caro, S.2    Covino, M.3
  • 22
    • 0242403368 scopus 로고    scopus 로고
    • A randomised trial of yogurt for prevention of antibiotic-associated diarrhoea
    • Beniwal RS, Arena VC, Thomas L etal. A randomised trial of yogurt for prevention of antibiotic-associated diarrhoea. Dig Dis Sci 2003; 48: 2077-2082.
    • (2003) Dig Dis Sci , vol.48 , pp. 2077-2082
    • Beniwal, R.S.1    Arena, V.C.2    Thomas, L.3
  • 23
    • 18144414625 scopus 로고    scopus 로고
    • Effect of the prebiotic oligofructose on relapse of Clostridium difficile-associated diarrhoea: a randomised, controlled study
    • Lewis S, Burmeister S, Brazier J. Effect of the prebiotic oligofructose on relapse of Clostridium difficile-associated diarrhoea: a randomised, controlled study. Clin Gastroenterol Hepatol 2005; 3: 442-448.
    • (2005) Clin Gastroenterol Hepatol , vol.3 , pp. 442-448
    • Lewis, S.1    Burmeister, S.2    Brazier, J.3
  • 24
    • 84887390865 scopus 로고    scopus 로고
    • Lactobacilli and Bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial
    • Allen S, Wareham K, Wang D etal. Lactobacilli and Bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial. Lancet 2013; 382: 1249-1257.
    • (2013) Lancet , vol.382 , pp. 1249-1257
    • Allen, S.1    Wareham, K.2    Wang, D.3
  • 25
    • 84943365104 scopus 로고    scopus 로고
    • Americans warming to probiotics, says datamonitor
    • Lorraine H. Americans warming to probiotics, says datamonitor, 2009. Available from: nutraingredients-usa.com.
    • (2009)
    • Lorraine, H.1
  • 26
    • 84943365728 scopus 로고    scopus 로고
    • Opportunities in digestive and immunity health: consumer attitudes and behaviors
    • Datamonitor. Opportunities in digestive and immunity health: consumer attitudes and behaviors. 2009.
    • (2009)
  • 27
    • 77954219248 scopus 로고    scopus 로고
    • Consumer attitudes toward functional foods/foods for health
    • International Food Information Council. Consumer attitudes toward functional foods/foods for health. 2007.
    • (2007)
  • 28
    • 60949109794 scopus 로고    scopus 로고
    • Consumer valuation of functional foods and nutraceuticals in Canada. A conjoint study using probiotics
    • Hailu G, Boecker A, Henson S, Cranfield J. Consumer valuation of functional foods and nutraceuticals in Canada. A conjoint study using probiotics. Appetite 2009; 52: 257-265.
    • (2009) Appetite , vol.52 , pp. 257-265
    • Hailu, G.1    Boecker, A.2    Henson, S.3    Cranfield, J.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.